DiNuzzo Private Wealth’s GoodRx Holdings GDRX Stock Holding History

DiNuzzo Private Wealth’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$35	–	1431
2024 Q3	$35	Sell	5 -1	-17%	-$8	﹤0.01%	1416
2024 Q2	$47	Buy	6 +1	+20%	+$7	﹤0.01%	1381
2024 Q1	$36	Hold	5	–	–	﹤0.01%	1340
2023 Q4	$34	Buy	+5	New	+$28	﹤0.01%	1372

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DiNuzzo Private Wealth's GDRX Position: Q4 2024 in Review

DiNuzzo Private Wealth sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 5 shares — an estimated $35 sold.

DiNuzzo Private Wealth first reported a position in GDRX in Q4 2023 and held it in 4 quarters. The position peaked at $47 in Q2 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

DiNuzzo Private Wealth reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
DiNuzzo Private Wealth sold 5 GoodRx Holdings shares in Q4 2024, an estimated $35.
DiNuzzo Private Wealth first reported a position in GoodRx Holdings in Q4 2023 and held it in 4 quarters.
DiNuzzo Private Wealth's GoodRx Holdings position peaked at $47 in Q2 2024.
170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on DiNuzzo Private Wealth's 13F filing for Q4 2024, filed 23 Jan 2025.